Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Impact of rotavirus vaccination: the importance of monitoring strains.

Gentsch JR, Parashar UD, Glass RI.

Future Microbiol. 2009 Dec;4(10):1231-4. doi: 10.2217/fmb.09.105. No abstract available.

2.

Rotavirus disease and vaccination: impact on genotype diversity.

Matthijnssens J, Bilcke J, Ciarlet M, Martella V, Bányai K, Rahman M, Zeller M, Beutels P, Van Damme P, Van Ranst M.

Future Microbiol. 2009 Dec;4(10):1303-16. doi: 10.2217/fmb.09.96. Review.

PMID:
19995190
3.

Group A rotavirus universal mass vaccination: how and to what extent will selective pressure influence prevalence of rotavirus genotypes?

Matthijnssens J, Nakagomi O, Kirkwood CD, Ciarlet M, Desselberger U, Van Ranst M.

Expert Rev Vaccines. 2012 Nov;11(11):1347-54. doi: 10.1586/erv.12.105. Review.

PMID:
23249234
4.

Systematic review of regional and temporal trends in global rotavirus strain diversity in the pre rotavirus vaccine era: insights for understanding the impact of rotavirus vaccination programs.

Bányai K, László B, Duque J, Steele AD, Nelson EA, Gentsch JR, Parashar UD.

Vaccine. 2012 Apr 27;30 Suppl 1:A122-30. doi: 10.1016/j.vaccine.2011.09.111. Review.

PMID:
22520121
5.

Epidemiology. Does viral diversity matter?

Medley GF, Nokes DJ.

Science. 2009 Jul 17;325(5938):274-5. doi: 10.1126/science.1177475. No abstract available.

PMID:
19608903
6.

Evidence of vaccine-related reassortment of rotavirus, Brazil, 2008-2010.

Rose TL, Marques da Silva MF, Goméz MM, Resque HR, Ichihara MY, Volotão Ede M, Leite JP.

Emerg Infect Dis. 2013 Nov;19(11):1843-6. doi: 10.3201/eid1911.121407.

7.

Real-world impact of rotavirus vaccination.

Patel MM, Steele D, Gentsch JR, Wecker J, Glass RI, Parashar UD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S1-5. doi: 10.1097/INF.0b013e3181fefa1f. Review. No abstract available.

PMID:
21183833
8.

[Epidemiological overview of rotavirus infection in Asia].

Zhang CF, Jia LY.

Zhongguo Dang Dai Er Ke Za Zhi. 2006 Feb;8(1):79-82. Review. Chinese. No abstract available.

PMID:
16522250
9.

United States rotavirus strain surveillance from 2005 to 2008: genotype prevalence before and after vaccine introduction.

Hull JJ, Teel EN, Kerin TK, Freeman MM, Esona MD, Gentsch JR, Cortese MM, Parashar UD, Glass RI, Bowen MD; National Rotavirus Strain Surveillance System.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S42-7. doi: 10.1097/INF.0b013e3181fefd78.

PMID:
21183839
10.

Genetic and antigenic diversity of human rotaviruses: potential impact on vaccination programs.

Kirkwood CD.

J Infect Dis. 2010 Sep 1;202 Suppl:S43-8. doi: 10.1086/653548. Review.

11.

Laboratory-based rotavirus surveillance during the introduction of a vaccination program, Brazil, 2005-2009.

Carvalho-Costa FA, Volotão Ede M, de Assis RM, Fialho AM, de Andrade Jda S, Rocha LN, Tort LF, da Silva MF, Gómez MM, de Souza PM, Leite JP.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S35-41. doi: 10.1097/INF.0b013e3181fefd5f.

PMID:
21048523
12.

Use of Internet search data to monitor impact of rotavirus vaccination in the United States.

Desai R, Lopman BA, Shimshoni Y, Harris JP, Patel MM, Parashar UD.

Clin Infect Dis. 2012 May;54(9):e115-8. doi: 10.1093/cid/cis121. Epub 2012 Mar 14.

13.

Hospital-based surveillance to evaluate the impact of rotavirus vaccination in São Paulo, Brazil.

Sáfadi MA, Berezin EN, Munford V, Almeida FJ, de Moraes JC, Pinheiro CF, Racz ML.

Pediatr Infect Dis J. 2010 Nov;29(11):1019-22. doi: 10.1097/INF.0b013e3181e7886a.

PMID:
20543761
14.

Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Belém, Brazil.

Justino MC, Linhares AC, Lanzieri TM, Miranda Y, Mascarenhas JD, Abreu E, Guerra SF, Oliveira AS, da Silva VB, Sanchez N, Meyer N, Shafi F, Ortega-Barria E, Soriano-Gabarró M, Colindres RE.

Pediatr Infect Dis J. 2011 May;30(5):396-401. doi: 10.1097/INF.0b013e3182055cc2.

PMID:
21150692
15.

Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium.

Parashar U, Steele D, Neuzil K, Quadros Cd, Tharmaphornpilas P, Serhan F, Santosham M, Patel M, Glass R.

Expert Rev Vaccines. 2013 Feb;12(2):113-7. doi: 10.1586/erv.12.148.

PMID:
23414403
16.

Genotypes of the circulating rotavirus strains in the seven prevaccine seasons from September 2000 to August 2007 in South Korea.

Jeong HS, Lee KB, Jeong AY, Jo MY, Jung SY, Ahn JH, Jee Y, Kim J, Cheon DS.

Clin Microbiol Infect. 2011 Feb;17(2):232-5. doi: 10.1111/j.1469-0691.2010.03232.x.

17.

Rotavirus P[4]G2 in a vaccinated population, Brazil.

Patel MM, de Oliveira LH, Bispo AM, Gentsch J, Parashar UD.

Emerg Infect Dis. 2008 May;14(5):863-5. doi: 10.3201/eid1405.071440. No abstract available.

18.

Rotavirus landscape in Africa-Towards prevention and control: A report of the 8th African rotavirus symposium, Livingstone, Zambia.

Rudd C, Mwenda J, Chilengi R.

Vaccine. 2015 Jun 26;33(29):3263-7. doi: 10.1016/j.vaccine.2015.04.002. Epub 2015 May 6.

PMID:
25957665
19.

Predominance of rotavirus P[4]G2 in a vaccinated population, Brazil.

Gurgel RQ, Cuevas LE, Vieira SC, Barros VC, Fontes PB, Salustino EF, Nakagomi O, Nakagomi T, Dove W, Cunliffe N, Hart CA.

Emerg Infect Dis. 2007 Oct;13(10):1571-3. doi: 10.3201/eid1310.070412.

20.

Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.

Nakagomi T, Cuevas LE, Gurgel RG, Elrokhsi SH, Belkhir YA, Abugalia M, Dove W, Montenegro FM, Correia JB, Nakagomi O, Cunliffe NA, Hart CA.

Arch Virol. 2008;153(3):591-3. doi: 10.1007/s00705-007-0028-z. Epub 2008 Jan 4.

PMID:
18175037
Items per page

Supplemental Content

Write to the Help Desk